Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms.
Proteins that control the excitability of neurons, including voltage-dependent ion channels and neurotransmitter receptors, reside in a membrane lipid environment that includes sphingomyelin, but the influence of the metabolism of this lipid on excitability is unknown. Sphingomyelin in the plasma membrane can be cleaved by neutral sphingomyelinases (nSMase) to generate ceramides and sphingosine-1-phosphate (S1P) which have been shown to play a variety of roles in cellular signaling processes. We found that application of nSMase to hippocampal slices results in a selective enhancement in the population spike amplitude, resulting in fEPSP-PS potentiation of the CA3-CA1 schaeffer collateral synapse. Single cell recordings showed that nSMase activity increases action potential frequency in CA1 neurons in a reversible manner. Additional current clamp recordings showed that nSMase reduces the slow after-hyperpolarization after a burst of action potentials. Mass spectrometry-based measurements demonstrated that nSMase activity induces a rapid increase in the levels of ceramides and S1P in cells in hippocampal slices. The ability of nSMase to increase CA1 neuron excitability was blocked by an inhibitor of sphingosine kinase, the enzyme that converts ceramide to S1P. Moreover, direct intracellular application of S1P to CA1 neurons increased action potential firing. Our findings suggest roles for sphingomyelin metabolism and S1P in the positive regulation of the excitability of hippocampal neurons.
Norman
Eric
E
Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, NIH Biomedical Research Center, Baltimore, Maryland 21224, USA.
Cutler
Roy G
RG
Flannery
Richard
R
Wang
Yue
Y
Mattson
Mark P
MP
D000200:Action Potentials; D000818:Animals; D056547:CA1 Region, Hippocampal / Q000502:physiology*; D002462:Cell Membrane / Q000378:metabolism*; D002518:Ceramides / Q000096:biosynthesis; D004789:Enzyme Activation; D019706:Excitatory Postsynaptic Potentials; D006868:Hydrolysis; D066298:In Vitro Techniques; D008246:Lysophospholipids / Q000096:biosynthesis / Q000502:physiology*; D008297:Male; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000502:physiology; D017966:Pyramidal Cells / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism; D013109:Sphingomyelins / Q000378:metabolism*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000502:physiology
D002518:Ceramides; D008246:Lysophospholipids; D015221:Potassium Channels; D013109:Sphingomyelins; C060506:sphingosine 1-phosphate; D013108:Sphingomyelin Phosphodiesterase; D013110:Sphingosine
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4662-7
10200319
J Neurosci. 2005 Mar 9;25(10):2609-16
15758171
J Biol Chem. 2001 Jun 8;276(23):20589-96
11279185
J Physiol. 2008 Jul 1;586(13):3113-27
18450779
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14512-7
12391303
Cell Death Differ. 2006 May;13(5):852-60
16397579
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2070-5
14970312
Nat Neurosci. 2007 Nov;10(11):1395-7
17934457
Cardiovasc Res. 2009 May 1;82(2):175-83
19176603
Synapse. 2000 Feb;35(2):151-9
10611641
Neurosci Lett. 1992 Nov 9;146(2):176-8
1337194
J Neurosci Methods. 1999 Oct 30;93(1):61-7
10598865
Trends Cardiovasc Med. 2004 Feb;14(2):37-42
15030787
Eur J Neurosci. 2001 Jul;14(2):203-9
11553273
J Neurosci Res. 2008 Oct;86(13):2867-75
18543334
J Physiol. 2006 Aug 15;575(Pt 1):101-13
16740613
Ann Neurol. 2002 Oct;52(4):448-57
12325074
J Physiol. 2002 Oct 15;544(2):385-402
12381813
Neuroscience. 2000;96(2):253-8
10683565
J Neurosci. 2002 Aug 15;22(16):7234-43
12177218
Neurology. 2007 May 1;68(18):1481-7
17470750
J Neurosci. 2009 Apr 15;29(15):4750-5
19369544
J Biol Chem. 1996 Aug 2;271(31):18431-6
8702487
Mol Cell Biol. 2007 May;27(9):3429-40
17325039
J Neurochem. 2002 Aug;82(4):809-18
12358786
J Neurochem. 1989 Feb;52(2):611-8
2536078
J Neurophysiol. 1980 Feb;43(2):409-19
6247461
Mol Cell Neurosci. 2008 Jun;38(2):213-23
18411055
Biochim Biophys Acta. 1990 Dec 14;1030(2):251-7
2261487
Ann Neurol. 2004 Feb;55(2):257-67
14755730
Biochemistry. 1996 Jan 16;35(2):626-33
8555236
Circ Res. 2000 Feb 4;86(2):198-204
10666416
Curr Opin Investig Drugs. 2008 Nov;9(11):1192-205
18951299
J Lipid Res. 2008 Jul;49(7):1388-94
18387885
J Neurosci. 2001 Jul 15;21(14):5121-9
11438587
Neuroreport. 2009 Jan 28;20(2):213-7
19057417
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3638-43
9520418
J Biol Chem. 2004 Jan 2;279(1):444-52
14559911
J Neurochem. 2009 Jun;109(5):1237-49
19476542
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2733-7
3458232
J Neurophysiol. 1986 Jun;55(6):1268-82
2426421
J Neurophysiol. 1993 Oct;70(4):1451-9
7904300
Ageing Res Rev. 2004 Nov;3(4):383-406
15541708
J Mol Neurosci. 2000 Oct;15(2):85-97
11220788
J Neurosci. 2003 Apr 15;23(8):3262-71
12716933
J Neurosci. 2006 Aug 23;26(34):8748-57
16928863